Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 360

1.

Immune globulin subcutaneous, human - klhw 20% for primary humoral immunodeficiency: an open-label, Phase III study.

Sleasman JW, Lumry WR, Hussain I, Wedner HJ, Harris JB, Courtney KL, Mondou E, Lin J, Stein MR.

Immunotherapy. 2019 Oct 17. doi: 10.2217/imt-2019-0159. [Epub ahead of print]

PMID:
31621458
2.

Posttranslational Regulation of IL-23 Production Distinguishes the Innate Immune Responses to Live Toxigenic versus Heat-Inactivated Vibrio cholerae.

Weil AA, Ellis CN, Debela MD, Bhuiyan TR, Rashu R, Bourque DL, Khan AI, Chowdhury F, LaRocque RC, Charles RC, Ryan ET, Calderwood SB, Qadri F, Harris JB.

mSphere. 2019 Aug 21;4(4). pii: e00206-19. doi: 10.1128/mSphere.00206-19.

3.

Pharmacists' Perspectives on Prescribing and Expanding Access to Hormonal Contraception in Pharmacies in the United States.

Rafie S, Cieri-Hutcherson NE, Frame TR, Griffin B, Harris JB, Horlen C, Shealy K, Stein AB, Stone RH, Vest K, Westberg S, Yancey AM.

J Pharm Pract. 2019 Aug 7:897190019867601. doi: 10.1177/0897190019867601. [Epub ahead of print]

PMID:
31390938
4.

Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh.

Akter A, Dash P, Aktar A, Jahan SR, Afrin S, Basher SR, Hakim A, Lisa AK, Chowdhury F, Khan AI, Xu P, Charles RC, Kelly M, Kováč P, Harris JB, Bhuiyan TR, Calderwood SB, Ryan ET, Qadri F.

PLoS Negl Trop Dis. 2019 Aug 1;13(8):e0007634. doi: 10.1371/journal.pntd.0007634. eCollection 2019 Aug.

5.

Vibriocidal Titer and Protection From Cholera in Children.

Ritter AS, Chowdhury F, Franke MF, Becker RL, Bhuiyan TR, Khan AI, Saha NC, Ryan ET, Calderwood SB, LaRocque RC, Harris JB, Qadri F, Weil AA.

Open Forum Infect Dis. 2019 Feb 11;6(4):ofz057. doi: 10.1093/ofid/ofz057. eCollection 2019 Apr.

6.

Evaluation of Lactation Compatibility Reference Recommendations.

Holmes AP, Harris JB, Ware S.

Ann Pharmacother. 2019 Sep;53(9):899-904. doi: 10.1177/1060028019839389. Epub 2019 Mar 24.

PMID:
30907111
7.

Post-processing of Large Bioactivity Data.

Harris JB.

Methods Mol Biol. 2019;1939:37-47. doi: 10.1007/978-1-4939-9089-4_3.

PMID:
30848455
8.

Estimating cholera incidence with cross-sectional serology.

Azman AS, Lessler J, Luquero FJ, Bhuiyan TR, Khan AI, Chowdhury F, Kabir A, Gurwith M, Weil AA, Harris JB, Calderwood SB, Ryan ET, Qadri F, Leung DT.

Sci Transl Med. 2019 Feb 20;11(480). pii: eaau6242. doi: 10.1126/scitranslmed.aau6242.

9.

Bivalent oral cholera vaccination induces a memory B cell response to the V. cholerae O1-polysaccharide antigen in Haitian adults.

Falkard B, Charles RC, Matias WR, Mayo-Smith LM, Jerome JG, Offord ES, Xu P, Kováč P, Ryan ET, Qadri F, Franke MF, Ivers LC, Harris JB.

PLoS Negl Trop Dis. 2019 Jan 31;13(1):e0007057. doi: 10.1371/journal.pntd.0007057. eCollection 2019 Jan.

10.

Cognate T and B cell interaction and association of follicular helper T cells with B cell responses in Vibrio cholerae O1 infected Bangladeshi adults.

Rashu R, Bhuiyan TR, Hoq MR, Hossain L, Paul A, Khan AI, Chowdhury F, Harris JB, Ryan ET, Calderwood SB, Weil AA, Qadri F.

Microbes Infect. 2019 Apr - May;21(3-4):176-183. doi: 10.1016/j.micinf.2018.12.002. Epub 2018 Dec 21.

11.

Introduction of inactivated poliovirus vaccine in the Philippines: Effect on health care provider and infant caregiver attitudes and practices.

Lopez AL, Harris JB, Raguindin PF, Aldaba J, Morales M, Sylim P, Wannemuehler K, Wallace A, Ehlman DC, Hyde TB, Fox KK, Nyambat B, Ducusin MJ, Hampton LM.

Vaccine. 2018 Nov 19;36(48):7399-7407. doi: 10.1016/j.vaccine.2018.09.028. Epub 2018 Oct 24.

12.

Cholera: Immunity and Prospects in Vaccine Development.

Harris JB.

J Infect Dis. 2018 Oct 15;218(suppl_3):S141-S146. doi: 10.1093/infdis/jiy414.

13.

Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study.

Franke MF, Ternier R, Jerome JG, Matias WR, Harris JB, Ivers LC.

Lancet Glob Health. 2018 Sep;6(9):e1028-e1035. doi: 10.1016/S2214-109X(18)30284-5.

14.

Defining endemic cholera at three levels of spatiotemporal resolution within Bangladesh.

Domman D, Chowdhury F, Khan AI, Dorman MJ, Mutreja A, Uddin MI, Paul A, Begum YA, Charles RC, Calderwood SB, Bhuiyan TR, Harris JB, LaRocque RC, Ryan ET, Qadri F, Thomson NR.

Nat Genet. 2018 Jul;50(7):951-955. doi: 10.1038/s41588-018-0150-8. Epub 2018 Jun 25.

15.

Spontaneous DNA damage to the nuclear genome promotes senescence, redox imbalance and aging.

Robinson AR, Yousefzadeh MJ, Rozgaja TA, Wang J, Li X, Tilstra JS, Feldman CH, Gregg SQ, Johnson CH, Skoda EM, Frantz MC, Bell-Temin H, Pope-Varsalona H, Gurkar AU, Nasto LA, Robinson RAS, Fuhrmann-Stroissnigg H, Czerwinska J, McGowan SJ, Cantu-Medellin N, Harris JB, Maniar S, Ross MA, Trussoni CE, LaRusso NF, Cifuentes-Pagano E, Pagano PJ, Tudek B, Vo NV, Rigatti LH, Opresko PL, Stolz DB, Watkins SC, Burd CE, Croix CMS, Siuzdak G, Yates NA, Robbins PD, Wang Y, Wipf P, Kelley EE, Niedernhofer LJ.

Redox Biol. 2018 Jul;17:259-273. doi: 10.1016/j.redox.2018.04.007. Epub 2018 Apr 13.

16.

Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh.

Aktar A, Rahman MA, Afrin S, Akter A, Uddin T, Yasmin T, Sami MIN, Dash P, Jahan SR, Chowdhury F, Khan AI, LaRocque RC, Charles RC, Bhuiyan TR, Mandlik A, Kelly M, Kováč P, Xu P, Calderwood SB, Harris JB, Qadri F, Ryan ET.

PLoS Negl Trop Dis. 2018 Apr 23;12(4):e0006399. doi: 10.1371/journal.pntd.0006399. eCollection 2018 Apr.

17.

Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae Infection.

Midani FS, Weil AA, Chowdhury F, Begum YA, Khan AI, Debela MD, Durand HK, Reese AT, Nimmagadda SN, Silverman JD, Ellis CN, Ryan ET, Calderwood SB, Harris JB, Qadri F, David LA, LaRocque RC.

J Infect Dis. 2018 Jul 13;218(4):645-653. doi: 10.1093/infdis/jiy192.

18.

Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection.

Haney DJ, Lock MD, Gurwith M, Simon JK, Ishioka G, Cohen MB, Kirkpatrick BD, Lyon CE, Chen WH, Sztein MB, Levine MM, Harris JB.

Vaccine. 2018 May 11;36(20):2768-2773. doi: 10.1016/j.vaccine.2018.04.011. Epub 2018 Apr 11.

19.

Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.

Islam K, Hossain M, Kelly M, Mayo Smith LM, Charles RC, Bhuiyan TR, Kováč P, Xu P, LaRocque RC, Calderwood SB, Simon JK, Chen WH, Haney D, Lock M, Lyon CE, Kirkpatrick BD, Cohen M, Levine MM, Gurwith M, Harris JB, Qadri F, Ryan ET.

PLoS Negl Trop Dis. 2018 Apr 6;12(4):e0006376. doi: 10.1371/journal.pntd.0006376. eCollection 2018 Apr.

20.

Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Final Report.

Casey RM, Harris JB, Ahuka-Mundeke S, Dixon MG, Kizito GM, Nsele PM, Umutesi G, Laven J, Kosoy O, Paluku G, Gueye AS, Hyde TB, Ewetola R, Sheria GKM, Muyembe-Tamfum JJ, Staples JE.

N Engl J Med. 2019 Aug 1;381(5):444-454. doi: 10.1056/NEJMoa1710430. Epub 2018 Feb 14.

21.

Dried Blood Spots for Measuring Vibrio cholerae-specific Immune Responses.

Iyer AS, Azman AS, Bouhenia M, Deng LO, Anderson CP, Graves M, Kováč P, Xu P, Ryan ET, Harris JB, Sack DA, Luquero FJ, Leung DT.

PLoS Negl Trop Dis. 2018 Jan 29;12(1):e0006196. doi: 10.1371/journal.pntd.0006196. eCollection 2018 Jan.

22.

Vibrio cholerae genomic diversity within and between patients.

Levade I, Terrat Y, Leducq JB, Weil AA, Mayo-Smith LM, Chowdhury F, Khan AI, Boncy J, Buteau J, Ivers LC, Ryan ET, Charles RC, Calderwood SB, Qadri F, Harris JB, LaRocque RC, Shapiro BJ.

Microb Genom. 2017 Dec;3(12). doi: 10.1099/mgen.0.000142.

23.

Poor continuity of care for TB diagnosis and treatment in Zambian Prisons: a situation analysis.

Hatwiinda S, Topp SM, Siyambango M, Harris JB, Maggard KR, Chileshe C, Kapata N, Reid SE, Henostroza G.

Trop Med Int Health. 2018 Feb;23(2):243-250. doi: 10.1111/tmi.13024. Epub 2018 Jan 16.

24.

The importance of human population characteristics in modeling Aedes aegypti distributions and assessing risk of mosquito-borne infectious diseases.

Obenauer JF, Andrew Joyner T, Harris JB.

Trop Med Health. 2017 Nov 15;45:38. doi: 10.1186/s41182-017-0078-1. eCollection 2017.

25.

Lessons Learned from Emergency Response Vaccination Efforts for Cholera, Typhoid, Yellow Fever, and Ebola.

Walldorf JA, Date KA, Sreenivasan N, Harris JB, Hyde TB.

Emerg Infect Dis. 2017 Dec;23(13). doi: 10.3201/eid2313.170550.

26.

Analysis of the Human Mucosal Response to Cholera Reveals Sustained Activation of Innate Immune Signaling Pathways.

Bourque DL, Bhuiyan TR, Genereux DP, Rashu R, Ellis CN, Chowdhury F, Khan AI, Alam NH, Paul A, Hossain L, Mayo-Smith LM, Charles RC, Weil AA, LaRocque RC, Calderwood SB, Ryan ET, Karlsson EK, Qadri F, Harris JB.

Infect Immun. 2018 Jan 22;86(2). pii: e00594-17. doi: 10.1128/IAI.00594-17. Print 2018 Feb.

27.

Assessing antigen specific HLA-DR+ antibody secreting cell (DR+ASC) responses in whole blood in enteric infections using an ELISPOT technique.

Bhuiyan TR, Hoq MR, Nishat NS, Al Mahbuba D, Rashu R, Islam K, Hossain L, Harris JB, Ryan ET, Calderwood SB, Svennerholm AM, Qadri F.

Microbes Infect. 2018 Feb;20(2):122-129. doi: 10.1016/j.micinf.2017.10.005. Epub 2017 Nov 8.

28.

Laboratory evaluation of immunochromatographic rapid diagnostic tests for cholera in Haiti.

Matias WR, Julceus FE, Abelard C, Mayo-Smith LM, Franke MF, Harris JB, Ivers LC.

PLoS One. 2017 Nov 1;12(11):e0186710. doi: 10.1371/journal.pone.0186710. eCollection 2017.

29.

Comparison of two control groups for estimation of oral cholera vaccine effectiveness using a case-control study design.

Franke MF, Jerome JG, Matias WR, Ternier R, Hilaire IJ, Harris JB, Ivers LC.

Vaccine. 2017 Oct 13;35(43):5819-5827. doi: 10.1016/j.vaccine.2017.09.025. Epub 2017 Sep 12.

30.

Financial Support to Eligible Countries for the Switch From Trivalent to Bivalent Oral Polio Vaccine-Lessons Learned.

Shendale S, Farrell M, Hampton LM, Harris JB, Kachra T, Kurji F, Patel M, Ramirez Gonzalez A, Zipursky S.

J Infect Dis. 2017 Jul 1;216(suppl_1):S57-S65. doi: 10.1093/infdis/jiw577.

31.

Experience With Inactivated Polio Vaccine Introduction and the "Switch" From Trivalent to Bivalent Oral Polio Vaccine in the World Health Organization's Western Pacific Region.

Gurung S, Harris JB, Eltayeb AO, Hampton LM, Diorditsa S, Avagyan T, Schluter WW.

J Infect Dis. 2017 Jul 1;216(suppl_1):S101-S108. doi: 10.1093/infdis/jiw574.

32.

Acceptance of the Administration of Multiple Injectable Vaccines in a Single Immunization Visit in Albania.

Preza I, Subaiya S, Harris JB, Ehlman DC, Wannemuehler K, Wallace AS, Huseynov S, Hyde TB, Nelaj E, Bino S, Hampton LM.

J Infect Dis. 2017 Jul 1;216(suppl_1):S146-S151. doi: 10.1093/infdis/jiw570.

33.

Household and Individual Risk Factors for Cholera among Cholera Vaccine Recipients in Rural Haiti.

Matias WR, Teng JE, Hilaire IJ, Harris JB, Franke MF, Ivers LC.

Am J Trop Med Hyg. 2017 Aug;97(2):436-442. doi: 10.4269/ajtmh.16-0407. Epub 2017 Jul 19.

34.

The pet trade's role in defaunation.

Tingley MW, Harris JBC, Hua F, Wilcove DS, Yong DL.

Science. 2017 Jun 2;356(6341):916. doi: 10.1126/science.aan5158. No abstract available.

PMID:
28572357
35.

Plasma and Mucosal Immunoglobulin M, Immunoglobulin A, and Immunoglobulin G Responses to the Vibrio cholerae O1 Protein Immunome in Adults With Cholera in Bangladesh.

Charles RC, Nakajima R, Liang L, Jasinskas A, Berger A, Leung DT, Kelly M, Xu P, Kovác P, Giffen SR, Harbison JD, Chowdhury F, Khan AI, Calderwood SB, Bhuiyan TR, Harris JB, Felgner PL, Qadri F, Ryan ET.

J Infect Dis. 2017 Jul 1;216(1):125-134. doi: 10.1093/infdis/jix253.

36.

Neonatal Herpes Simplex Viral Infections and Acyclovir: An Update.

Harris JB, Holmes AP.

J Pediatr Pharmacol Ther. 2017 Mar-Apr;22(2):88-93. doi: 10.5863/1551-6776-22.2.88. Review.

37.

Measuring the impact of the pet trade on Indonesian birds.

Harris JB, Tingley MW, Hua F, Yong DL, Adeney JM, Lee TM, Marthy W, Prawiradilaga DM, Sekercioglu CH, Suyadi, Winarni N, Wilcove DS.

Conserv Biol. 2017 Apr;31(2):394-405. doi: 10.1111/cobi.12729. Epub 2016 Mar 31.

PMID:
28146342
38.

Bites by the Monocled Cobra, Naja kaouthia, in Chittagong Division, Bangladesh: Epidemiology, Clinical Features of Envenoming and Management of 70 Identified Cases.

Faiz MA, Ahsan MF, Ghose A, Rahman MR, Amin R, Hossain M, Tareq MNU, Jalil MA, Kuch U, Theakston RDG, Warrell DA, Harris JB.

Am J Trop Med Hyg. 2017 Apr;96(4):876-884. doi: 10.4269/ajtmh.16-0842. Epub 2017 Jan 30.

39.

Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells.

Kauffman RC, Bhuiyan TR, Nakajima R, Mayo-Smith LM, Rashu R, Hoq MR, Chowdhury F, Khan AI, Rahman A, Bhaumik SK, Harris L, O'Neal JT, Trost JF, Alam NH, Jasinskas A, Dotsey E, Kelly M, Charles RC, Xu P, Kováč P, Calderwood SB, Ryan ET, Felgner PL, Qadri F, Wrammert J, Harris JB.

MBio. 2016 Dec 20;7(6). pii: e02021-16. doi: 10.1128/mBio.02021-16.

40.

The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae.

Mayo-Smith LM, Simon JK, Chen WH, Haney D, Lock M, Lyon CE, Calderwood SB, Kirkpatrick BD, Cohen M, Levine MM, Gurwith M, Harris JB.

Clin Vaccine Immunol. 2017 Jan 5;24(1). pii: e00470-16. doi: 10.1128/CVI.00470-16. Print 2017 Jan.

41.

Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children.

Uddin MI, Islam S, Nishat NS, Hossain M, Rafique TA, Rashu R, Hoq MR, Zhang Y, Saha A, Harris JB, Calderwood SB, Bhuiyan TR, Ryan ET, Leung DT, Qadri F.

PLoS Negl Trop Dis. 2016 Nov 8;10(11):e0005039. doi: 10.1371/journal.pntd.0005039. eCollection 2016 Nov.

42.

Investigation of the Li-S Battery Mechanism by Real-Time Monitoring of the Changes of Sulfur and Polysulfide Species during the Discharge and Charge.

Zheng D, Liu D, Harris JB, Ding T, Si J, Andrew S, Qu D, Yang XQ, Qu D.

ACS Appl Mater Interfaces. 2017 Feb 8;9(5):4326-4332. doi: 10.1021/acsami.6b08904. Epub 2016 Sep 23.

PMID:
27612389
43.

A magneto-DNA nanoparticle system for the rapid and sensitive diagnosis of enteric fever.

Park KS, Chung HJ, Khanam F, Lee H, Rashu R, Bhuiyan MT, Berger A, Harris JB, Calderwood SB, Ryan ET, Qadri F, Weissleder R, Charles RC.

Sci Rep. 2016 Sep 8;6:32878. doi: 10.1038/srep32878.

44.

Acceptance of multiple injectable vaccines in a single immunization visit in The Gambia pre and post introduction of inactivated polio vaccine.

Idoko OT, Hampton LM, Mboizi RB, Agbla SC, Wallace AS, Harris JB, Sowe D, Ehlman DC, Kampmann B, Ota MO, Hyde TB.

Vaccine. 2016 Sep 22;34(41):5034-5039. doi: 10.1016/j.vaccine.2016.07.021. Epub 2016 Aug 25.

PMID:
27570237
45.

Ensemble-based docking: From hit discovery to metabolism and toxicity predictions.

Evangelista W, Weir RL, Ellingson SR, Harris JB, Kapoor K, Smith JC, Baudry J.

Bioorg Med Chem. 2016 Oct 15;24(20):4928-4935. doi: 10.1016/j.bmc.2016.07.064. Epub 2016 Jul 29.

46.

Resurrecting the chimera: Progressions in parenting and peer processes.

Forgatch MS, Snyder JJ, Patterson GR, Pauldine MR, Chaw Y, Elish K, Harris JB, Richardson EB.

Dev Psychopathol. 2016 Aug;28(3):689-706. doi: 10.1017/S0954579416000250.

PMID:
27427800
47.

Cholera and ABO Blood Group: Understanding an Ancient Association.

Harris JB, LaRocque RC.

Am J Trop Med Hyg. 2016 Aug 3;95(2):263-264. doi: 10.4269/ajtmh.16-0440. Epub 2016 Jul 11. No abstract available.

48.

High prevalence of tuberculosis in newly enrolled HIV patients in Zambia: need for enhanced screening approach.

Henostroza G, Harris JB, Chitambi R, Siyambango M, Turnbull ER, Maggard KR, Krüüner A, Kapata N, Reid SE.

Int J Tuberc Lung Dis. 2016 Aug;20(8):1033-9. doi: 10.5588/ijtld.15.0651.

PMID:
27393536
49.

Antibody Secreting Cell Responses following Vaccination with Bivalent Oral Cholera Vaccine among Haitian Adults.

Matias WR, Falkard B, Charles RC, Mayo-Smith LM, Teng JE, Xu P, Kováč P, Ryan ET, Qadri F, Franke MF, Ivers LC, Harris JB.

PLoS Negl Trop Dis. 2016 Jun 16;10(6):e0004753. doi: 10.1371/journal.pntd.0004753. eCollection 2016 Jun.

50.

O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh.

Aktar A, Rahman MA, Afrin S, Faruk MO, Uddin T, Akter A, Sami MIN, Yasmin T, Chowdhury F, Khan AI, Leung DT, LaRocque RC, Charles RC, Bhuiyan TR, Mandlik A, Kelly M, Kováč P, Xu P, Calderwood SB, Harris JB, Qadri F, Ryan ET.

Clin Vaccine Immunol. 2016 May 6;23(5):427-435. doi: 10.1128/CVI.00647-15. Print 2016 May.

Supplemental Content

Loading ...
Support Center